GLMD Galmed Pharmaceuticals Ltd.

8.13
+0.00  (0%)
Previous Close 8.13
Open 7.85
Price To book 15.94
Market Cap 103523453
Shares 12,733,512
Volume 0
Short Ratio 0.95
Av. Daily Volume 37,567

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 2Q 2018.
Aramchol - ARREST
Non-Alcoholic Steatohepatitis (NASH)
Phase 2 top-line data due 1Q 2018.
Aramchol - ARRIVE
HIV-associated lipodystrophy and nonalcoholic fatty liver disease (NAFLD)

Latest News

  1. Galmed Pharmaceuticals reports 3Q loss
  2. Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
  3. Galmed Pharmaceuticals Ltd. to Host Earnings Call
  4. Galmed Pharmaceuticals to Provide Corporate Overview at the Stifel 2017 Healthcare Conference
  5. Galmed Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 9th
  6. Galmed Pharmaceuticals to Host Key Opinion Leader Meeting on Non-Alcoholic Steato-Hepatitis (NASH)
  7. Galmed Pharmaceuticals Announces Publication of Data on Aramchol™ Mechanism of Action in Hepatology Communications. Data Will Also Be Presented at AASLD
  8. 3 Reasons Why Galmed Pharmaceuticals (GLMD) is a Great Momentum Stock
  9. Galmed Pharmaceuticals Announces Pricing of Offering of Ordinary Shares to Existing Investors and Members of the Board of Directors
  10. Galmed Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
  11. Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%
  12. Galmed Pharmaceuticals Second Quarter 2017 Conference Call and Webcast Scheduled for Monday, July 31, 2017
  13. Galmed Pharmaceuticals Announces the Election of Dr. Carol L. Brosgart as a New Member of the Board of Directors
  14. Galmed Pharmaceuticals Reports First Quarter 2017 Financial Results
  15. Galmed Pharmaceuticals First Quarter 2017 Conference Call and Webcast Scheduled for Monday, May 15th, 2017
  16. Galmed Pharmaceuticals to Present at International Liver Congress Data that Shows Aramchol™ has a Potential Direct Effect on Liver Fibrosis
  17. Galmed Pharmaceuticals Fourth Quarter 2016 Conference Call and Webcast Scheduled for Thursday, March 23rd, 2017